{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:50:15Z","timestamp":1788544215057,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicine in Drug Discovery"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.medidd.2020.100039","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T23:49:28Z","timestamp":1587253768000},"page":"100039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["PAK1-blockers: Potential Therapeutics against COVID-19"],"prefix":"10.1016","volume":"6","author":[{"given":"Hiroshi","family":"Maruta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medidd.2020.100039_bb0005","doi-asserted-by":"crossref","unstructured":"Gordon CJ, Tchesnokov EP, Feng JY, et al (2020). The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem. pii: jbc.AC120.013056.","DOI":"10.1074\/jbc.AC120.013056"},{"issue":"2","key":"10.1016\/j.medidd.2020.100039_bb0010","first-page":"418","article-title":"Tackling the Coronaviral Infection: Blocking Either the \u201cPathogenic\u201d Kinase PAK1 or RNA-dependent RNA Polymerase (RdRP)","volume":"8","author":"Maruta","year":"2020","journal-title":"J Infect Dis Ther"},{"key":"10.1016\/j.medidd.2020.100039_bb0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ptr.5054","article-title":"Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity","volume":"28","author":"Maruta","year":"2014","journal-title":"Phytother Res"},{"key":"10.1016\/j.medidd.2020.100039_bb0020","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.lfs.2004.11.015","article-title":"Downregulation of Rac1 activation by caffeic acid in aortic smooth muscle cells","volume":"76","author":"Xu","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.medidd.2020.100039_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.medidd.2020.100039_bb0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2016.04.105","article-title":"Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation","volume":"474","author":"Oh","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.medidd.2020.100039_bb0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/ATVBAHA.119.313757","article-title":"PTEN (Phosphatase and Tensin Homolog) Protects Against Ang II (Angiotensin II)-Induced Pathological Vascular Fibrosis and Remodeling-Brief Report","volume":"40","author":"Lu","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.medidd.2020.100039_bb0040","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1128\/JVI.02560-09","article-title":"Upregulation of the chemokine (C-C motif) ligand 2 (CCL2) via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol."},{"key":"10.1016\/j.medidd.2020.100039_bb0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12885-017-3432-0","article-title":"Depletion of p21-activated kinase 1 (PAK1) up-regulates the immune system of APC\u220614\/+ mice and inhibits intestinal tumorigenesis","volume":"17","author":"Huynh","year":"2017","journal-title":"BMC Cancer."},{"key":"10.1016\/j.medidd.2020.100039_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF01941717","article-title":"Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis","volume":"44","author":"Grunberger","year":"1988","journal-title":"Experientia"},{"key":"10.1016\/j.medidd.2020.100039_bb0055","first-page":"110","article-title":"Frondoside A from Sea Cucumber and Nymphaeols from Okinawa Propolis: Natural anti-cancer agents that selectively inhibit PAK1 in vitro, Drug Discov","volume":"11","author":"Nguyen","year":"2017","journal-title":"Ther."},{"key":"10.1016\/j.medidd.2020.100039_bb0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2017.07.043","article-title":"From bench (laboratory) to bed (hospital\/home): How to explore effective natural and synthetic PAK1-blockers\/Longevity-promoters for cancer therapy","volume":"142","author":"Maruta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.medidd.2020.100039_bb0065","series-title":"Melatonin: Your Body's Natural Wonder Drug","author":"Reiter","year":"1995"},{"key":"10.1016\/j.medidd.2020.100039_bb0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5582\/ddt.2016.01062","article-title":"The serum\/PDGF-dependent \u201cmelanogenic\u201d role of the minute level of the oncogenic kinase PAK1 in melanoma cells proven by the highly sensitive kinase assay","volume":"10","author":"Be Tu","year":"2017","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.medidd.2020.100039_bb0075","doi-asserted-by":"crossref","unstructured":"Allen JD, Jaffer ZM, Park SJ, et al. (2009). p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood. 19;113(12):2695\u2013705.","DOI":"10.1182\/blood-2008-06-160861"},{"key":"10.1016\/j.medidd.2020.100039_bb0080","doi-asserted-by":"crossref","unstructured":"Choi HS, Kim SL, Kim JH, Lee DS (2020). The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation. Int J Mol Sci, 21(3). pii: E1014.","DOI":"10.3390\/ijms21031014"},{"key":"10.1016\/j.medidd.2020.100039_bb0085","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2008.04.056","article-title":"Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells","volume":"589","author":"Liou","year":"2008","journal-title":"Eur J Pharmacol."},{"key":"10.1016\/j.medidd.2020.100039_bb0090","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1021\/acs.jmedchem.5b01329","article-title":"Phosphonooxymethyl Prodrug of Triptolide (Minnelide): Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts","volume":"58","author":"Patil","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.medidd.2020.100039_bb0095","first-page":"243","article-title":"Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines","volume":"3","author":"Hashimoto","year":"2009","journal-title":"Drug Discov Ther."},{"key":"10.1016\/j.medidd.2020.100039_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CAD.0b013e3283212ade","article-title":"Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo","volume":"20","author":"Chen","year":"2009","journal-title":"Anticancer Drugs."},{"key":"10.1016\/j.medidd.2020.100039_bb0105","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1462-5822.2011.01582.x","article-title":"Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes","volume":"13","author":"Sicard","year":"2011","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.medidd.2020.100039_bb0110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.bjp.0707137","article-title":"Investigation of the immune-suppressive activity of artemether on T-cell activation and proliferation","volume":"150","author":"Wang","year":"2007","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.medidd.2020.100039_bb0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4161\/cbt.5.3.2404","article-title":"Sichuan pepper extracts block the PAK1\/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice","volume":"5","author":"Hirokawa","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.medidd.2020.100039_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/excr.1998.4027","article-title":"FK228, a potent anti-tumor antibiotic, is a novel histone deacetylase inhibitor","volume":"241","author":"Nakajima","year":"1998","journal-title":"Exp Cell Res."},{"key":"10.1016\/j.medidd.2020.100039_bb0125","doi-asserted-by":"crossref","first-page":"956","DOI":"10.4161\/cbt.4.9.1911","article-title":"Signal therapy of breast cancer xenograft in mice by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance","volume":"4","author":"Hirokawa","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.medidd.2020.100039_bb0130","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine (HQ) and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"20","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.medidd.2020.100039_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/ol.2017.6103","article-title":"Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2-mediated signaling pathways in lung cancer","volume":"14","author":"Li","year":"2017","journal-title":"Oncol Lett."},{"key":"10.1016\/j.medidd.2020.100039_bb0140","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1535-7163.MCT-15-0419","article-title":"R-ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis","volume":"14","author":"Guo","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.medidd.2020.100039_bb0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2016.11.038","article-title":"1,2,3-Triazolyl ester of Ketorolac: A \u201cClick Chemistry\u201d-based highly potent PAK1-blocking cancer-killer","volume":"126","author":"Nguyen","year":"2016","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.medidd.2020.100039_bb0150","first-page":"248","article-title":"1,2,3-Triazolyl Ester of Ketorolac (15\u202fK), a Potent PAK1-Blocker","volume":"13","author":"Hennig","year":"2019","journal-title":"Inhibits Both Growth and Metastasis of Human Pancreatic Cancer Orthotopic Xenografts in Mice. Drug Discov.Ther."},{"key":"10.1016\/j.medidd.2020.100039_bb0155","first-page":"21","article-title":"Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3","volume":"47","author":"Eisman","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.medidd.2020.100039_bb0160","first-page":"3547","article-title":"Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 (MART-10) as a therapeutic agent for androgen-dependent prostate cancer","volume":"29","author":"Flanagan","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.medidd.2020.100039_bb0165","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1159\/000453197","article-title":"1\u03b1,25 (OH) 2D3 Induces Actin Depolymerization in Endometrial Carcinoma Cells by Targeting RAC1 and PAK1","volume":"40","author":"Zeng","year":"2016","journal-title":"Cell Physiol Biochem."},{"key":"10.1016\/j.medidd.2020.100039_bb0170","doi-asserted-by":"crossref","unstructured":"Chiang KC, Yeh TS, Chen SC, et al. (2016). The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential. Int J Mol Sci. 17, pii: E606.","DOI":"10.3390\/ijms17040606"},{"key":"10.1016\/j.medidd.2020.100039_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1074\/jbc.275.1.47","article-title":"Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction","volume":"275","author":"Dwivedi","year":"2000","journal-title":"J Biol Chem."}],"container-title":["Medicine in Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590098620300269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590098620300269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:39:28Z","timestamp":1762911568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590098620300269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":35,"alternative-id":["S2590098620300269"],"URL":"https:\/\/doi.org\/10.1016\/j.medidd.2020.100039","relation":{},"ISSN":["2590-0986"],"issn-type":[{"value":"2590-0986","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAK1-blockers: Potential Therapeutics against COVID-19","name":"articletitle","label":"Article Title"},{"value":"Medicine in Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medidd.2020.100039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100039"}}